Eric Nuermberger

PROFESSOR

19992019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1999 2019

Filter
Review article
2019

Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research

Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 othersSassetti, C. M., Sizemore, C. F., Winthrop, K. L. & Zelazny, A. M., Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.

Research output: Contribution to journalReview article

Lung
Infection
Research
2018

Long-acting formulations for the treatment of latent tuberculous infection: Opportunities and challenges

Swindells, S., Siccardi, M., Barrett, S. E., Olsen, D. B., Grobler, J. A., Podany, A. T., Nuermberger, E., Kim, P., Barry, C. E., Owen, A., Hazuda, D. & Flexner, C. W., Feb 1 2018, In : International Journal of Tuberculosis and Lung Disease. 22, 2, p. 125-132 8 p.

Research output: Contribution to journalReview article

Tuberculosis
Infection
HIV
Drug Compounding
Virus Diseases

New drugs and regimens for tuberculosis

Chang, K. C., Nuermberger, E., Sotgiu, G. & Leung, C. C., Nov 1 2018, In : Respirology. 23, 11, p. 978-990 13 p.

Research output: Contribution to journalReview article

Multidrug-Resistant Tuberculosis
Drug Repositioning
Tuberculosis
Drug Resistance
Pharmaceutical Preparations
2017

Drug resistance mechanisms and novel drug targets for tuberculosis therapy

Islam, M. M., Hameed, H. M. A., Mugweru, J., Chhotaray, C., Wang, C., Tan, Y., Liu, J., Li, X., Tan, S., Ojima, I., Yew, W. W., Nuermberger, E., Lamichhane, G. & Zhang, T., Jan 20 2017, In : Journal of Genetics and Genomics. 44, 1, p. 21-37 17 p.

Research output: Contribution to journalReview article

Drug Resistance
Tuberculosis
Pharmaceutical Preparations
Multidrug-Resistant Tuberculosis
Therapeutics

Preclinical Efficacy Testing of New Drug Candidates

Nuermberger, E., Jun 1 2017, In : Microbiology spectrum. 5, 3

Research output: Contribution to journalReview article

chemotherapy
drug
Latent Tuberculosis
Drug Therapy
Drug Combinations

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., Theron, G., van Helden, P., Niemann, S., Merker, M., Dowdy, D. W., Van Rie, A., Siu, G. K. H., Pasipanodya, J. G., Rodrigues, C., Clark, T. G. & 22 othersSirgel, F. A., Esmail, A., Lin, H. H., Atre, S. R., Schaaf, H. S., Chang, K. C., Lange, C., Nahid, P., Udwadia, Z. F., Horsburgh, C. R., Churchyard, G. J., Menzies, D., Hesseling, A. C., Nuermberger, E., McIlleron, H., Fennelly, K. P., Goemaere, E., Jaramillo, E., Low, M., Jara, C. M., Padayatchi, N. & Warren, R. M., Apr 1 2017, In : The Lancet Respiratory Medicine. 5, 4, p. 291-360 70 p.

Research output: Contribution to journalReview article

Extensively Drug-Resistant Tuberculosis
Epidemiology
Tuberculosis
Multidrug-Resistant Tuberculosis
Linezolid
2016
Linezolid
Tuberculosis
Multidrug-Resistant Tuberculosis
Mitochondrial Proteins
Pharmaceutical Preparations